ClinicalTrials.gg
RecruitingNCT07025057Updated Jul 7, 2026

Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities

An interventional study of Provider training in Provider Confidence and Provider Behavior, sponsored by Michigan State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Michigan State University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Feb 2025, registered Jun 2025).
  • Started Feb 2025; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
480
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of the study involving human subjects is to train providers to address patient-provider interactions. The study will survey providers to assess pre-post knowledge, understanding, and behavior changes.

Read the detailed description

Provider/practice level intervention. The study will address patient-provider interactions through actionable, experiential provider trainings focused on communication provider, cultural relevance, and awareness of and referrals to community care services including CHWs and HV, for both clinical and community settings. Trainings are rooted in both history and in current research about how to address maternal mortality disparities, and will include self-learning, didactics, reflection, discussion, and identifying ways to tailor trainees settings to better hear, respect, and meet the needs of perinatal NHB/H women.

02

Conditions studied

  • Provider Confidence
  • Provider Behavior

Browse trials for

Keywords

  • Maternal mortality
  • Maternal morbidity
03

In context

Maternal Death

77 studies on the registry are indexed under Maternal Death; 19 are open to participants now.

This study's planned enrollment of 480 is below the median of 1,126 across 57 interventional studies indexed under Maternal Death.

Browse Maternal Death studies →

Lead sponsor

Michigan State University is the lead sponsor of 143 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Providing care to pregnant and postpartum women in Wayne, Kent, and Genesee Counties in MI

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
480 participants (estimated)

Study arms

  • Experimental
    Provider training

    The providers in this arm will receive training

    Behavioral: Provider training

Interventions

  • BehavioralProvider training

    The study will address patient-provider interactions through actionable, experiential provider trainings focused on communication provider, cultural relevance, and awareness of and referrals to community care services including Community Health Workers (CHW) and home visiting, for both clinical and community settings. Trainings are rooted in both history and in current research about how to address maternal mortality disparities, and will include self-learning, didactics, reflection, discussion, and identifying ways to tailor trainees settings to better hear, respect, and meet the needs of perinatal Black and Hispanic women.

06

What researchers measure

Primary outcomes

  1. Provider confidence. Assessed through questionnaire.

    Pre-post intervention change in provider confidence regarding provider-patient interactions

    Time frame: Assessment immediately after the provider training intervention

07

Study locations

1 of 1 sites recruiting
  • Strong Beginings
    Grand Rapids, Michigan 49503, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The study is collecting data and later will be sharing project-generated data according to NIH's requirements for depositing relevant de-identified data into appropriate NIH data archives.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Aug 2029, 53 months after the start.

Of 35 interventional studies with no phase under Maternal Death, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 41. This study's planned 53 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2025
First posted
Jun 17, 2025
StartActual
Feb 3, 2025
Primary completionEst.
Aug 1, 2029
CompletionEst.
Aug 15, 2030
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07025057
Responsible party
Cristian Meghea (Associate Professor, Michigan State University) — Principal investigator
First posted
Jun 17, 2025
Start date
Feb 3, 2025
Primary completion
Aug 1, 2029 (estimated)
Completion
Aug 15, 2030 (estimated)
Last update
Jul 7, 2026

Study contacts

Jennifer Raffo, MA
Contact
overfiel@msu.edu
12487161043
Cristian Meghea, PhD
principal investigator · Michigan State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion